Skip to content

Clinical trials

Cardiovascular Diseases trials in Serbia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cardiovascular Diseases Country / region: Serbia Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20091
20101
20111
20122
20151
20161
20171
20181
20192
20232
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Recruiting3
Active, not recruiting2
Enrolling by invitation2
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Heidelberg University2
United Therapeutics2
Alnylam Pharmaceuticals1
Boehringer Ingelheim1
CSL Behring1
Esperion Therapeutics, Inc.1
Genfit1
GlaxoSmithKline1
Medtronic1
Menarini International Operations Luxembourg SA1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cardiovascular Diseases18
Hypertension7
Vascular Diseases4
Coronary Artery Disease3
Heart Diseases3
Kidney Failure, Chronic3
Connective Tissue Diseases2
Diabetes Mellitus, Type 22
Disease Progression2
Familial Primary Pulmonary Hypertension2

Trials

Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.